Trademark: 86892639
Word
HYRTAZ
Status
Dead
Status Code
710
Status Date
Friday, March 24, 2023
Serial Number
86892639
Registration Number
5040373
Registration Date
Tuesday, September 13, 2016
Mark Type
4000
Filing Date
Monday, February 1, 2016
Published for Opposition
Tuesday, June 28, 2016
Cancellation Date
Friday, March 24, 2023

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Mar 24, 2023
Cancelled Sec. 8 (6-Yr)
Nov 8, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 8, 2022
Teas Change Of Correspondence Received
Nov 8, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 8, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 8, 2022
Teas Change Of Owner Address Received
Sep 13, 2021
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Sep 13, 2016
Registered-Principal Register
Jun 28, 2016
Official Gazette Publication Confirmation E-Mailed
Jun 28, 2016
Published For Opposition
Jun 8, 2016
Notification Of Notice Of Publication E-Mailed
May 20, 2016
Approved For Pub - Principal Register
May 17, 2016
Assigned To Examiner
Feb 4, 2016
New Application Office Supplied Data Entered
Feb 4, 2016
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24